The U.S. Food and Drug Administration (FDA) has designated Fast Track status to a new therapeutic drug therapy for the treatment of malignant pleural mesothelioma (MPM) in patients with unresectable NF2-deficient tumors. The drug, IK-930, was granted ...

This past April, the Environmental Protection Agency proposed banning the use, manufacture and import of the most pervasive type of asbestos, chrysotile. Although advocates continued to demand a complete ban of all forms of asbestos, the EPA’s ...